We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00237965
First Posted: October 13, 2005
Last Update Posted: December 9, 2005
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Brown University
  Purpose
This study aims to improve Skin Self-Examination accuracy by a simple cost effective intervention requiring participants to complete a mole-mapping diagram.

Condition Intervention
Melanoma Behavioral: Mole Mapping Diagram

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Official Title: The Use of Mole Mapping Diagrams to Increase Skin Self Examination Accuracy

Resource links provided by NLM:


Further study details as provided by Brown University:

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male and female subjects above age 18 of any ethnicity will be enrolled in this study.

Exclusion Criteria:

  • Subjects will be excluded from the study if they have significant skin disease which would not allow manipulation of their photographs consistent with the rest of the subjects.
  • Since the study instructions are in English, Non-English speakers will be excluded.
  • Those with co-morbidity sufficiently severe to prevent them from being able to perform a SSE will be excluded.
  • In addition, those with cognitive impairment who are unable to give informed consent, or to understand the study instructions given to them, will be excluded.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00237965


Sponsors and Collaborators
Brown University
Investigators
Principal Investigator: Martin A Weinstock, MD, Ph.D Veterans Affairs Medical Center Providence, RI
  More Information

ClinicalTrials.gov Identifier: NCT00237965     History of Changes
Other Study ID Numbers: 00001402
First Submitted: October 11, 2005
First Posted: October 13, 2005
Last Update Posted: December 9, 2005
Last Verified: May 2004

Keywords provided by Brown University:
Skin Self Examination
Mole Mapping Diagram
Melanoma

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas